Details for Patent: 8,162,915

Which drugs does patent 8,162,915 protect, and when does it expire?

Patent 8,162,915 protects NAROPIN and is included in one NDA.

This patent has twenty-five patent family members in nineteen countries.

Summary for Patent: 8,162,915

Title:	Connector for packings containing medical liquids, and corresponding packing for medical liquids
Abstract:	A connector for packings containing medical liquids, particularly infusion, transfusion or enteral bags, comprises a connecting part (1) for accommodating a spike for drawing out the liquid and comprises a closure part (3) that closes the passage (2) inside the connecting part (1). The connecting part (1) has an elastically deformable pinching off part (4) provided in the form of a tubular section with a non-circular cross-section. A base part (5), which widens on both sides is adjoined to said pinching off part (4) and can be integrated in the packing. During manufacturing, the packing is filled with liquid via the connecting part. After filling, the pinching off part is pressed together whereby preventing liquid from escaping. Afterwards, the closure part is placed onto the connecting part. The manufacturing of the packing is simplified by virtue of the fact that an additional tube for connecting the connector and packing is rendered unnecessary.
Inventor(s):	Brandenburger; Torsten (Niddatal, DE), Heilmann; Klaus (St. Wendel, DE), Knierbein; Bernd (Neu-Anspach, DE)
Assignee:	Fresenius Kabi Deutschland GmbH (Bad Homburg, DE)
Application Number:	10/550,477
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,162,915
Patent Claim Types: see list of patent claims	Device;

Drugs Protected by US Patent 8,162,915

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Fresenius Kabi Usa	NAROPIN	ropivacaine hydrochloride	SOLUTION;INJECTION	020533-006	Sep 24, 1996	AP	RX	Yes	No			Y
Fresenius Kabi Usa	NAROPIN	ropivacaine hydrochloride	SOLUTION;INJECTION	020533-007	Sep 24, 1996	AP	RX	Yes	No			Y

Foreign Priority and PCT Information for Patent: 8,162,915

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	103 13 760	Mar 27, 2003

PCT Information
PCT Filed	January 22, 2004	PCT Application Number:	PCT/EP2004/000487
PCT Publication Date:	October 07, 2004	PCT Publication Number:	WO2004/084793

International Family Members for US Patent 8,162,915

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	407653
Australia	2004224795
Brazil	PI0408780